[Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma].

Kentaro Takahashi, K Takahashi, S Kijima, K Yoshino, Kiyoshi Yoshino, T Shibukawa, Toshihiko Shibukawa, Masashi Moriyama, M Moriyama, O Iwanari, Osamu Iwanari, Katsuhiro Sawada, K Sawada, I Matsunaga, F Murao, Fuminori Murao, M Kitao, Manabu Kitao
Nihon Sanka Fujinka Gakkai zasshi · 1985 · vol. 37(4) , pp. 591–5 · PMID:3857281 · W2416126169
article OA: closed CC0 ⤵ 7 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

Serum CA 125 levels were significantly higher in women with adenomyosis (93.3 U/ml) than in those with leiomyomata uteri (18.3 U/ml), differentiating these conditions preoperatively.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To differentiate pre-operatively between leiomyomata uteri and adenomyosis, we measured serum levels of an antigen (CA 125) common to most nonmucinous epithelial ovarian carcinoma in patients with benign uterine tumor (11 of leiomyomata uteri, 7 of adenomyosis and 1 of adenomyosis with leiomyomata uteri). CA 125 in serum samples pre and postoperatively were measured using an RIA Kit. The normal range of CA 125 levels was below 35U/ml. The mean CA 125 level (+/- S.D.) was 18.3 +/- 6.1U/ml in patients with leiomyomata uteri and 93.3 +/- 49.4U/ml in those with adenomyosis. Student's t-test showed a significant correlation (0.001 less than p less than 0.01). The mean CA 125 level in patients with adenomyosis was statistically higher than that in disease-free women. Among 7 patients with surgically demonstrable adenomyosis, the CA 125 values were over 35U/ml (87.5%). In all 11 patients with surgically demonstrable leiomyomata uteri, the CA 125 level was below 35U/ml. The CA 125 level in patients with adenomyosis gradually decreased postoperatively and in all was below 35U/ml up to one month postoperatively. Using this approach, leiomyomata uteri and adenomyosis can be differentiated, pre-operatively.

My notes (saved in your browser only)

Condition tags

mesh:D004715adenomyosis

MeSH descriptors

Antigens, Neoplasm Endometriosis Leiomyoma Uterine Neoplasms Antigens, Neoplasm Antigens, Tumor-Associated, Carbohydrate Diagnosis, Differential Endometriosis Endometriosis Female Humans Leiomyoma Leiomyoma Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (7)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:45.632124+00:00
License: CC0 · commercial use OK